Machine Vision Technology Gives Solar Cell Manufacturers New Opportunities to Increase Productivity and Lower Costs

DALSA Corporation (TSX: DSA), a global leader in machine vision technology, today announced its entrance into the solar cell inspection market. The company's efficiencies and expertise in area scan, line scan, and embedded processing for inspection in the flat-panel display industry are now being successfully applied to solar cell inspection, resulting in high quality, yet cost-effective inspection capabilities for the solar cell industry.

"The solar cell inspection market demands high quality and high volume production; this is where DALSA's capabilities provide a distinct competitive advantage," comments Philip Colet, Vice President of Sales and Marketing at DALSA. Machine vision is used for three general purposes by solar cell manufacturers: product inspection; identification and tracking; and lastly, product assembly. "DALSA's cameras and hardware are used in the initial part of the quality inspection process to verify patterns and edges, inspect coatings, and to check for micro-cracks. The precision of DALSA's image capture and processing technology contributes to the immediate and accurate detection of defects in this critical stage of the manufacturing process."

Solar cell manufacturers are under pressure to drive down costs in order to achieve "grid parity," the point at which the cost of solar energy is roughly equivalent to the cost of conventional power distributed on electric grids. Analysts forecast that his may occur in 2011 as module prices continue to drop. Ted Sullivan, Lux Research analyst and lead author of the report "Finding the Solar Market's Nadir," says, "As costs come down, you unlock bigger and bigger portions of the market."

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.